These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia]. Diop S, Letestu R, Orsolani D, Leboeuf Y, Le Tutour P, Thiam D, Diakhate L, Valensi F. Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759 [Abstract] [Full Text] [Related]
3. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals. Prieto A, Garcia-Suarez J, Reyes E, Lapeña P, Hernandez M, Alvarez-Mon M. Exp Hematol; 1993 Nov; 21(12):1563-9. PubMed ID: 8405237 [Abstract] [Full Text] [Related]
7. Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia. Lopez-Matas M, Rodriguez-Justo M, Morilla R, Catovsky D, Matutes E. Haematologica; 2000 Nov; 85(11):1140-5. PubMed ID: 11064465 [Abstract] [Full Text] [Related]
9. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease. Grywalska E, Bartkowiak-Emeryk M, Pasiarski M, Olszewska-Bożek K, Mielnik M, Podgajna M, Pieczykolan M, Hymos A, Fitas E, Surdacka A, Góźdź S, Roliński J. Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517 [Abstract] [Full Text] [Related]
10. Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human-->mouse radiation chimera. Shimoni A, Marcus H, Dekel B, Shkarchi R, Arditti F, Shvidel L, Shtalrid M, Bucher W, Canaan A, Ergas D, Berrebi A, Reisner Y. Cancer Res; 1999 Dec 01; 59(23):5968-74. PubMed ID: 10606243 [Abstract] [Full Text] [Related]
11. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution. Mao Z, Quintanilla-Martinez L, Raffeld M, Richter M, Krugmann J, Burek C, Hartmann E, Rudiger T, Jaffe ES, Müller-Hermelink HK, Ott G, Fend F, Rosenwald A. Am J Surg Pathol; 2007 Oct 01; 31(10):1605-14. PubMed ID: 17895764 [Abstract] [Full Text] [Related]
18. Different expression of CD3 and CD22 in leukemic cells according to whether tested in suspension or fixed on slides. Rani S, De Oliveira MS, Catovsky D. Hematol Pathol; 1988 May 01; 2(2):73-8. PubMed ID: 2974027 [Abstract] [Full Text] [Related]
19. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia. Panayiotidis P, Ganeshaguru K, Foroni L, Hoffbrand AV. Leukemia; 1995 Jul 01; 9(7):1227-32. PubMed ID: 7543175 [Abstract] [Full Text] [Related]